J. Long

机构：Chongqing University, Chongqing Cancer Hospital, Dali University

发表论文 7 篇 · 总被引 16 次 · h-index 3

代表论文

• 357P: Association of TROP2 quantitative continuous scoring (QCS) normalised membrane ratio (NMR) with efficacy in Chinese patients (pts) with advanced/metastatic non-small cell lung cancer (a/mNSCLC) treated with datopotamab deruxtecan (Dato-DXd) in TROPION-PanTumor02 (2025 · Journal of Thoracic Oncology · 被引 7)
• 2379P AVENANCE: Subgroup analysis of patients (pts) with advanced urothelial carcinoma (aUC) with histological variants from a real-world (RW) study of avelumab first-line maintenance (1LM) (2023 · Annals of Oncology · 被引 4)
• OA01.08 A Phase I Study to Evaluate Safety and Antitumor Activity of BPI-7711 in EGFRM+/T790M+ Advanced or Recurrent NSCLC Patients (2019 · Journal of Thoracic Oncology · 被引 4)
• A phase I study to evaluate safety and efficacy of BPI-7711 in EGFRm+/T790M+ advanced or recurrent NSCLC patients (2019 · Annals of Oncology · 被引 1)
• Genetic Analysis of the Conserved Population of Dengchuan Cattle Based on High Concordance SNP loci (2025 · Animals)
• P2.09-06 Efficacy and Safety of Aumolertinib as Second- Or Third-Line Therapy in EGFR T790M Negative/Unknown Non-small Cell Lung Cancer (2023 · Journal of Thoracic Oncology)